Serina Therapeutics(SER)
HUNTSVILLE, ALBiotechnology
Focus: Serina Therapeutics is a public biotech company founded in 1967 specializing in small molecules attached to polymers for neurological diseases. The company is early-stage with minimal commercial revenue and a focused pipeline of two Phase 1 programs in Parkinson's disease.
Profile data last refreshed 9h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Serina Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Serina Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Serina Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$56K
Pipeline & Clinical Trials
SER-252
PARKINSON DISEASE (Disorder)Clinical Trials (1)
NCT07422675SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Phase 1Help build intelligence for Serina Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.